Can a weekly injection ease the burden of short bowel syndrome?
Disease control
Recruiting now
This phase 3 trial is testing whether apraglutide, a synthetic version of a natural gut hormone, can help adults with short bowel syndrome and intestinal failure reduce their need for intravenous nutrition (parenteral support). Participants receive either apraglutide or a placebo…
Phase 3 • Sponsor: VectivBio AG • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC